Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 26.02 BRL 2.56% Market Closed
Market Cap: 44.6B BRL
Have any thoughts about
Raia Drogasil SA?
Write Note

Net Margin
Raia Drogasil SA

3%
Current
3%
Average
1.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3%
=
Net Income
1.1B
/
Revenue
37.7B

Net Margin Across Competitors

Country BR
Market Cap 44.6B BRL
Net Margin
3%
Country ZA
Market Cap 98.2B Zac
Net Margin
6%
Country ZA
Market Cap 31.9B Zac
Net Margin
3%
Country US
Market Cap 7.5B USD
Net Margin
-6%
Country JP
Market Cap 845.2B JPY
Net Margin
5%
Country SA
Market Cap 16.8B SAR
Net Margin
9%
Country CN
Market Cap 27.3B CNY
Net Margin
6%
Country MX
Market Cap 70.6B MXN
Net Margin
4%
Country JP
Market Cap 547.7B JPY
Net Margin
3%
Country NL
Market Cap 2.9B EUR
Net Margin
-1%
Country JP
Market Cap 457.5B JPY
Net Margin
3%
No Stocks Found

Raia Drogasil SA
Glance View

Market Cap
44.6B BRL
Industry
Retail

Raia Drogasil SA is a leading retail pharmacy chain in Brazil, established through the merger of two prominent companies, Raia and Drogasil, creating a powerhouse in the pharmaceutical and personal care sectors. With a mission to cater to the healthcare and wellness needs of Brazilians, the company operates over 2,300 stores across key urban regions, boasting a comprehensive product range that includes prescription medications, over-the-counter drugs, beauty products, and health-related services. Investors are drawn to Raia Drogasil for its strong market position, supported by a consistent strategy of expansion, innovation, and a commitment to customer service, making it a trusted name in the fast-growing Brazilian pharmaceutical market. In recent years, Raia Drogasil has implemented advanced sales and inventory management systems to enhance operational efficiency and customer satisfaction. The company's focus on growth is further reinforced by a robust online presence, enabling it to capture emerging e-commerce trends among Brazilian consumers. With a resilient business model, anchored by a broad geographic footprint and an increasingly diverse product offering, Raia Drogasil stands poised for long-term success. As Brazil's middle class continues to expand and healthcare spending rises, the company presents a compelling opportunity for investors looking to tap into a thriving market with promising growth potential.

RADL3 Intrinsic Value
20.8 BRL
Overvaluation 20%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
3%
=
Net Income
1.1B
/
Revenue
37.7B
What is the Net Margin of Raia Drogasil SA?

Based on Raia Drogasil SA's most recent financial statements, the company has Net Margin of 3%.